So proud of the diabetes team here @unibirmingham and @CQehb for getting everything together to administer Teplizumab to the first person on the NHS.
This has taken years with lots of international collaborative working to become a reality.
This has taken years with lots of international collaborative working to become a reality.
We're delighted to hear that Queen Elizabeth Hospital Birmingham has treated its first person with teplizumab, following NHS approval earlier this year.
Teplizumab is the first disease-modifying treatment for type 1 diabetes and can delay the need to take insulin by an average of around three years.
This is an important step towards changing how we approach type 1 diabetes – moving from managing the condition after symptoms have appeared to intervening before someone needs to take insulin.
Congratulations to the team at Queen Elizabeth Hospital Birmingham!
Now let's make sure this is just the start.
Every eligible person, wherever they live, should have the opportunity to access teplizumab. This progress needs to be replicated across the UK.
Read the full story here: bit.ly/4sKitT3
#Teplizumab #GBDoc #ResearchView quoted post on X
